Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: The use of dalteparin may be able to prevent complications caused by the use of a
catheter to supply chemotherapy to cancer patients. It is not yet known if dalteparin is
effective in reducing these complications.
PURPOSE: Randomized phase III trial to determine the effectiveness of dalteparin in
preventing catheter-related complications in cancer patients who are receiving chemotherapy
through a catheter.